Cover Image

HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia

Bibliographic Details
Main Authors:	Vojvodová, A. (Author), Danko, Ján, 1950- (Author), Višňovský, Jozef, 1960- (Author), Dókuš, Karol, 1973- (Author), Kajo, Karol, 1962-2026 (Author), Plank, Lukáš, 1951- (Author), Szunyogh, Norbert (Author), Galajda, Peter, 1960- (Author), Žúbor, Pavol, 1975- (Author), Lasabová, Zora, 1964- (Author), Biringer, K (Author)
Format:	Article
Language:	English

Similar Items

Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases
by: Naidu, R., et al.

The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome
by: Kortsaris, A., et al.

Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer
by: Kortsaris, A., et al.

Evaluation of predictive and prognostic significance of serum TGF-ß1 levels in breast cancer according to HER-2 codon 655 polymorphism
by: Kortsaris, A., et al.

Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population
by: Štanclová, A., et al.